Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Romosozumab Versus Denosumab in Patients With Glucocorticoid-induced Osteoporosis: a 2-year Extension Study of a Randomized Controlled Trial

NCT06472050 is registered in ClinicalTrials.gov with Tuen Mun Hospital as lead sponsor.

NCT NCT06472050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Romosozumab Versus Denosumab in Patients With Glucocorticoid-induced Osteoporosis: a 2-year Extension Study of a Randomized Controlled Trial
Lead sponsor
Tuen Mun Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 20, 2024
Completion date
April 30, 2026
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glucocorticoids toxicity, osteoporosis